PMID: 38185350 Sci Rep Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation
About the Experts Vishwanath Venketaraman, Ph.D., is a professor of microbiology and immunology at the Western University of Health Sciences who has been researching glutathione for more than 20 years
What to track Keep a simple daily log that records bowel movement frequency (how many per day), stool consistency (use the Bristol Stool Scale, aiming for Type 3 or 4), ease of passage (straining versus comfortable), abdominal symptoms (bloating, cramping, gas), water intake (in ounces), fiber intake (approximate grams), exercise (type and duration), and any supplements or laxatives used
Results indicate predispositions in peptide-pathway activationnot exact medication response or side-effect prediction
Melanie Cree, director of the University of Colorados PCOS multidisciplinary clinic and pediatric endocrinologist at Childrens Hospital Colorado, is the main investigator on a clinical trial testing semaglutide in 80 obese girls and women with PCOS aged 12 to 35
BPC-157 works by promoting tissue regeneration and modulating various physiological processes in the body